POTOMAC, MD / ACCESSWIRE / / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ...
Innovative use of geofencing technology boosts enrollment at select sites POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced to ...
IGC Pharma, Inc. (NYSE:IGC) shares made small progress Wednesday, on word its ongoing Phase 2 trial for agitation in Alzheimer's disease has been officially named CALMA (Calming Agitation in Alzheimer ...
With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a filing for FDA approval ...
In one study, the company’s drug eased the agitation for Alzheimer’s patients. In a different study, there wasn’t a ...
A resident who lived across the hall from Hsia in the facility's memory care unit left her bleeding and unconscious on the ...
Analyst Sumant Kulkarni from Canaccord Genuity maintained a Buy rating on Bioxcel Therapeutics (BTAI – Research Report) and decreased the price ...
The News Leader (Staunton) on MSN2d
Staunton's Patrick Webb balances life as a caregiver for his wife living with Alzheimer'sPatrick and Carol Webb had lived all over the world. Thirty years serving in the army, while Webb was gone, Carol took care ...
DSP-2342 is under clinical development by Sumitomo Pharma America and currently in Phase I for Unspecified Psychiatric Disorders.
Stifel Nicolaus analyst Paul Matteis has maintained their bullish stance on NMRA stock, giving a Buy rating today.Don't Miss Our New Year's ...
TEL AVIV, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback